Kopran has received an approval for sale of Consumer Care Division with effect from April 01, 2015 along with all its assets and liabilities. The board of directors at their meeting held on July 14, 2015 has approved for the same.
Kopran is currently an integrated Pharmaceutical Company manufacturing a large range of products. It manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.